Book 30.08% Gains in Your Tech Options

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world.

It was a positive week overall for markets, with the Dow Jones up 0.80% and the S&P 500 rising an even 1.00%, hitting yet another record high. Notwithstanding the crisis in Ukraine, the MCSI Emerging Markets Index ended the week essentially flat.

Big gainers in your Bull Market Alert portfolio included last week’s recommendation, Micron Technology Inc. (MU), up 2.35%; Grifols SA (GRFS), which gained 1.76%; and Thermo Fisher Scientific, Inc. (TMO), which rose 1.71%. The latter two also hit new 52-week highs. AbbVie (ABBV) also moved back above its 50-day moving average and is now a BUY.

With Google (GOOG) stock flattening out over the past few weeks, book your 30.08% gains in your April $1180 call options (GOOG140419C01180000). I will likely revisit this position again on any pull back in the stock.

Last Monday, you were stopped out of Russian search engine Yandex (YNDX). I recommended this position during the glory of the Sochi Olympics and you were stopped out during the height of the subsequent Ukrainian crisis. Russia has an uncanny ability to disappoint those willing to venture into its shark-infested investment waters!

All of your current Bull Market Alert positions are showing a profit for the year. But with the market overbought over the short term, and market internals deteriorating, I am holding off on making a new Bull Market Alert recommendation this week.

Today is an historic day, as it is the five-year anniversary of the S&P 500 hitting bottom in 2009, closing at 676.53. That low marked a climax of a 16-month sell-off during which the S&P 500 lost one-half of its value. Since then, the Standard & Poor’s 500 index has gained more than 177%, the best rolling five-year performance since the June 1996 to June 2000 period that covers the dot-com bubble.

Exclusive  Back into a Semiconductor Play and Booking 227.44% Option Gains

That is a powerful statistic, and yet another testament to the power of contrarian investing.

Portfolio Update

Bank of Ireland (IRE) gave back 13.43% last week after Wilbur Ross and Fairfax Financial divested some of their large IRE positions. As this divestiture was a small 6.4% sale relative to Ross’ much larger holding of around 35%, Ross is still long on the stock in a big way. The current pullback has no impact on the continuing improving fundamentals of the bank. In fact, I’d view it as an opportunity to add to your position. IRE remains a BUY.

AbbVie (ABBV) gained 1.08% over the past five trading days. Moody’s revised its outlook on ABBV to “Positive” early last week.  ABBV’s “inverted head and shoulders” chart pattern also produced a very bullish signal. ABBV rose above its 50-day moving average (MA) last Friday to become a BUY.

Thermo Fisher Scientific, Inc. (TMO) rose 1.71%. CNBC’s Jim Cramer interviewed TMO’s CEO, Marc Casper, last week and uncovered several positive comments. Mr. Casper highlighted TMO’s huge China presence and that the company has plans to deploy much more capital in 2015 in an effort to add to shareholder value. TMO is a BUY.

Grifols SA (GRFS) gained 1.76%. JP Morgan maintained its “Overweight” recommendation on GRFS last week. GRFS is a BUY.

Latest Special Report

As a courtesy, I invite you to take a look at the new 2014 version of The Top 12 Stocks You Should Buy Right Now, which features three of my top investment recommendations, as well as bonus picks from each of my fellow investment newsletter editors at Eagle. In addition, I want to bring to your attention my latest special report, Top 4 Keys to Profiting in the New Wildfire Rally. Both of these reports are available on my website FREE for you and other subscribers.

Exclusive  Portfolio Update: Preparing for the Q4 surge.

Nicholas Vardy

Like This Article?
Now Get Our FREE Special Report:
Alternative Investing: Investing in Timber

Stock Investor editor Paul Dykewicz reveals why investing in timber may be one of the best long-term portfolio strategies you'll find today.

Get Access to the Report, 100% FREE


img
previous article

Jobs growth beat forecasts while tensions in Ukraine continued; as a result, stocks made only a slight increase from yesterday's prices.

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

LEARN MORE HERE

Mike Turner

Mike Turner’s financial, mathematical, computer science and engineering background serves as the foundation for his disciplined, rules-based approach to trading. Mike’s three services include:

Product Details

LEARN MORE HERE

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details

LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

LEARN MORE HERE